Mesothelioma Cancer Resources Blog

Successful treatment of malignant pleural mesothelioma remains elusive for doctors, scientists, and researchers alike, leaving the prognosis for mesothelioma patients poor with a median survival of less than two years. Mesothelioma has proven to be chemoresistant, rendering many of the current chemotherapy treatments inadequate. According to an article published in the journal Current Drug Targets, …

Kentucky Senate Bill 62, designating Sept. 26 of each year as Mesothelioma Awareness Day, was approved by a committee in the Kentucky State Senate on Wednesday. If the bill is approved by the full Senate, the measure will go next to the Kentucky House of Representatives. The efforts by Kentucky lawmakers to establish a Mesothelioma …

TomoTherapy, a company that provides radiation treatment equipment, has named their recipients for the 2009-10 Clinical Investigation Grants. The grant program supports research on the clinical benefits of intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) for improving cancer care. Klaus Herfarth, M.D., of University of Heidelberg, Germany will use the grant to examine …

After lung surgery for mesothelioma in June 2006, doctors told Jon Matthews of England that he had only a few months left to live. Instead of giving up, in early 2007 he took his odds to his bookie and asked to place a bet that he would outlive his doctors’ predictions. Bookmaker William Hill accepted …

New York attorney Joseph Belluck, of Belluck & Fox, praised the Department of Defense for increasing their spending for research into the treatment of mesothelioma. “This boost in dollars finally recognizes a condition that has been overlooked and under-researched for far too long,” said Joseph W. Belluck. Mesothelioma is a rare, aggressive form of cancer …

A treatment known as chemoembolization, where anticancer drugs are injected directly into a cancer tumor, has shown effective in the treatment of mesothelioma according to its supporters being treated in Germany. However, the National Health Service (NHS), the publicly-funded healthcare system in England, is not convinced. England’s Department of Health says they do not have …

Joseph Belluck of New York law firm Belluck & Fox, and Michael Pietrykowski of San Francisco will co-chair the thirteenth annual National Asbestos Litigation Conference in September 2010. The conference, first held in 1998, is the companion conference to HB’s Emerging Trends in Asbestos Litigation Conference, being held in March. Belluck and Pietrykowski also co-chaired …

In contrast to previous findings, French researchers are reporting that the incidence of pleural mesothelioma among French men has begun a slight downward trend. For women, however, the incidence of mesothelioma has shown a significant increase. The findings covered data from 1980 to 2005, and were reported in the International Journal of Cancer. Pleural mesothelioma …

The International Union Against Cancer (UICC) initiated the World Cancer Campaign in 2005 to raise awareness of cancer prevention, and has declared today, February 4, 2010, as a global World Cancer Day. Used to raise people’s awareness of cancer and how to prevent, detect or treat it, World Cancer Day is the perfect opportunity to …

The most common chemotherapy treatment for malignant pleural mesothelioma is a combination therapy of cisplatin and pemetrexed. This combination is used as a first-line treatment in patients for which resection (surgery) is not an option, as well as in adjuvant chemotherapy treatment after surgery. This combination is effective, yet it can be toxic with a …